The Role of B Cells in Multiple Sclerosis: Implications for B-Cell-Targeted Therapy

Author(s): M. Hirotani , M. Niino , H. Sasaki .

Journal Name: Current Medicinal Chemistry

Volume 17 , Issue 28 , 2010

Abstract:

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. Although most studies have emphasized the role of T cells in the pathogenesis of MS, increasing evidence supports the concept that B cells play a key role in the pathogenesis of MS, mainly in association with the deposition of antibodies and the activation of complement. Emerging pathophysiological findings of B-cell, follicle-like structures in the meninges of patients and observations of decreased interleukin (IL)-10 production from naive B cells in MS have recently been reported. As more knowledge is gained of the pathophysiology of B cells in MS, the mechanisms of B-cell-mediated neuropharmacology of current therapy had been clarified as well. In this article, we review the increasing evidence that points to a link between B cells and MS, and also discuss the potential of B-cell-targeted therapy in MS.

Keywords: Multiple sclerosis, B cells, Autoantibody, Complement activation, Rituximab

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 28
Year: 2010
Page: [3215 - 3222]
Pages: 8
DOI: 10.2174/092986710792231969
Price: $58

Article Metrics

PDF: 25